Turkina A - Search Results

1

Whole-exome sequencing reveals potential molecular predictors of relapse after discontinuation of the targeted therapy in chronic myeloid leukemia patients.

Smirnikhina SA, Lavrov AV, Chelysheva EY, Adilgereeva EP, Shukhov OA, Turkina A, Kutsev SI. Smirnikhina SA, et al. Among authors: turkina a. Leuk Lymphoma. 2016 Jul;57(7):1669-76. doi: 10.3109/10428194.2015.1132420. Epub 2016 Jan 12. Leuk Lymphoma. 2016. PMID: 26759060

2

Prognostic value of P-glycoprotein and leukocyte differentiation antigens in chronic myeloid leukemia.

Stavrovskaya A, Turkina A, Sedyakhina N, Stromskaya T, Zabotina T, Khoroshko N, Baryshnikov A. Stavrovskaya A, et al. Among authors: turkina a. Leuk Lymphoma. 1998 Feb;28(5-6):469-82. doi: 10.3109/10428199809058354. Leuk Lymphoma. 1998. PMID: 9613976 Review.

3

Studies of some mechanisms of drug resistance in chronic myeloid leukemia (CML).

Turkina AG, Logacheva NP, Stromskaya TP, Zabotina TN, Kuznetzov SV, Sachibzadaeva KK, Tagiev A, Juravlev VS, Khoroshko ND, Baryshnikov AY, Stavrovskaya AA. Turkina AG, et al. Adv Exp Med Biol. 1999;457:477-88. doi: 10.1007/978-1-4615-4811-9_52. Adv Exp Med Biol. 1999. PMID: 10500825

4

[Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].

Kumas Sotiris, Semenova EA, Turkina AG, Zakharova AV, Domracheva EV, Khoroshko ND, Frank GA. Kumas Sotiris, et al. Among authors: turkina ag. Arkh Patol. 2003 Jul-Aug;65(4):9-12. Arkh Patol. 2003. PMID: 14518186 Russian.

5

Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis.

Nicolini FE, Masszi T, Shen Z, Gallagher NJ, Jootar S, Powell BL, Dorlhiac-Llacer PE, Zheng M, Szczudlo T, Turkina A. Nicolini FE, et al. Among authors: turkina a. Leuk Lymphoma. 2012 May;53(5):907-14. doi: 10.3109/10428194.2011.627480. Epub 2011 Dec 5. Leuk Lymphoma. 2012. PMID: 22023530 Clinical Trial.

6

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Experts in Chronic Myeloid Leukemia. Experts in Chronic Myeloid Leukemia. Blood. 2013 May 30;121(22):4439-42. doi: 10.1182/blood-2013-03-490003. Epub 2013 Apr 25. Blood. 2013. PMID: 23620577 Free PMC article.

7

The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib.

Hoffmann VS, Baccarani M, Lindoerfer D, Castagnetti F, Turkina A, Zaritsky A, Hellmann A, Prejzner W, Steegmann JL, Mayer J, Indrak K, Colita A, Rosti G, Pfirrmann M. Hoffmann VS, et al. Among authors: turkina a. Leukemia. 2013 Oct;27(10):2016-22. doi: 10.1038/leu.2013.171. Epub 2013 Jun 11. Leukemia. 2013. PMID: 23752173

8

The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries.

Hoffmann VS, Baccarani M, Hasford J, Lindoerfer D, Burgstaller S, Sertic D, Costeas P, Mayer J, Indrak K, Everaus H, Koskenvesa P, Guilhot J, Schubert-Fritschle G, Castagnetti F, Di Raimondo F, Lejniece S, Griskevicius L, Thielen N, Sacha T, Hellmann A, Turkina AG, Zaritskey A, Bogdanovic A, Sninska Z, Zupan I, Steegmann JL, Simonsson B, Clark RE, Covelli A, Guidi G, Hehlmann R. Hoffmann VS, et al. Among authors: turkina ag. Leukemia. 2015 Jun;29(6):1336-43. doi: 10.1038/leu.2015.73. Epub 2015 Mar 18. Leukemia. 2015. PMID: 25783795

9

The ability of multipotent mesenchymal stromal cells from the bone marrow of patients with leukemia to maintain normal hematopoietic progenitor cells.

Sorokina T, Shipounova I, Bigildeev A, Petinati N, Drize N, Turkina A, Chelysheva E, Shukhov O, Kuzmina L, Parovichnikova E, Savchenko V. Sorokina T, et al. Among authors: turkina a. Eur J Haematol. 2016 Sep;97(3):245-52. doi: 10.1111/ejh.12713. Epub 2016 Jan 3. Eur J Haematol. 2016. PMID: 26643284

10

Frequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia.

Lavrov AV, Chelysheva EY, Smirnikhina SA, Shukhov OA, Turkina AG, Adilgereeva EP, Kutsev SI. Lavrov AV, et al. Among authors: turkina ag. BMC Genet. 2016 Jan 27;17 Suppl 1(Suppl 1):14. doi: 10.1186/s12863-015-0308-7. BMC Genet. 2016. PMID: 26822197 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters